Cloud Pharmaceuticals Inc. is a drug development company with a unique in silico discovery capability. The company designs and develops new drugs for a wide range of therapeutic areas including cancer, inflammation, CNS disorders, and rare diseases. We partner extensively with for-profit, government, and academic organizations to jointly design and develop new drugs and then seek to partner with later-stage developers.
The true strength of the company is our ability to generate and efficiently develop novel molecules with new composition of matter IP and drug-like properties. We are a leader in the computational design of new drugs and subsequent rapid, information-driven drug development. Our approach accelerates the drug discovery and design process in a way that delivers tangible results and true value for our partners.